Oncoinvent ASA Net Assets
Oncoinvent ASA net assets. Based on the latest financial reports, Oncoinvent ASA (KLDVK) has net assets worth Nkr277.49 Million NOK (≈ $29.20 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr507.79 Million ≈ $53.43 Million USD) and total liabilities (Nkr230.30 Million ≈ $24.23 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See KLDVK equity financing ratio to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr277.49 Million |
| % of Total Assets | 54.65% |
| Annual Growth Rate | 25.38% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 31.46 |
Net Assets of Oncoinvent ASA (2021–2025)
Net assets of Oncoinvent ASA from 2021 to 2025. This chart illustrates how Oncoinvent ASA's net assets have evolved over time, based on quarterly financial data. Also explore Oncoinvent ASA (KLDVK) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Net Assets for Oncoinvent ASA (2021–2025)
The table below shows the annual net assets of Oncoinvent ASA from 2021 to 2025. For live market cap and overall valuation, see Oncoinvent ASA (KLDVK) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr277.49 Million ≈ $29.20 Million |
+3.63% |
| 2024-12-31 | Nkr267.76 Million ≈ $28.18 Million |
-5.62% |
| 2023-12-31 | Nkr283.70 Million ≈ $29.85 Million |
+47.75% |
| 2022-12-31 | Nkr192.02 Million ≈ $20.21 Million |
+71.03% |
| 2021-12-31 | Nkr112.27 Million ≈ $11.81 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Oncoinvent ASA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Oncoinvent ASA Net Assets Breakdown (December 2025)
Oncoinvent ASA net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | Nkr277.49 Million | 100.00% |
| Total Equity | Nkr277.49 Million | 100.00% |
Oncoinvent ASA Competitors by Market Cap
The table below lists competitors of Oncoinvent ASA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Thai Mitsuwa Public Company Limited
BK:TMW
|
$68.71 Million |
|
Tan Chong Motor Holdings Bhd
KLSE:4405
|
$68.71 Million |
|
Berjaya Food Bhd
KLSE:5196
|
$68.73 Million |
|
GIIR Inc
KO:035000
|
$68.76 Million |
|
Saunders International Ltd
AU:SND
|
$68.66 Million |
|
Scorpio Gold Corp
V:SGN
|
$68.66 Million |
|
Gold Pacific Co. Ltd
KQ:038530
|
$68.65 Million |
|
Mitrajaya Holdings Bhd
KLSE:9571
|
$68.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Oncoinvent ASA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 267,760,000 to 277,488,000, a change of 9,728,000 (3.6%).
- Net loss of 48,103,000 reduced equity.
- New share issuances of 46,628,000 increased equity.
- Other factors increased equity by 11,203,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-48.10 Million | -17.34% |
| Share Issuances | Nkr46.63 Million | +16.8% |
| Other Changes | Nkr11.20 Million | +4.04% |
| Total Change | Nkr- | 3.63% |
Book Value vs Market Value Analysis
This analysis compares Oncoinvent ASA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.35x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.89x to 2.35x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | Nkr2.05 | Nkr3.88 | x |
| 2022-12-31 | Nkr2.10 | Nkr3.88 | x |
| 2023-12-31 | Nkr2.32 | Nkr3.88 | x |
| 2024-12-31 | Nkr2.19 | Nkr3.88 | x |
| 2025-12-31 | Nkr1.65 | Nkr3.88 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Oncoinvent ASA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -17.34%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -42.85%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 1.83x
- Recent ROE (-17.34%) is below the historical average (-5.52%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 1.78% | 6.18% | 0.19x | 1.53x | Nkr-9.23 Million |
| 2022 | -2.62% | -8.89% | 0.18x | 1.62x | Nkr-24.24 Million |
| 2023 | 2.01% | 19.18% | 0.07x | 1.51x | Nkr-22.67 Million |
| 2024 | -11.43% | -29.96% | 0.21x | 1.80x | Nkr-57.39 Million |
| 2025 | -17.34% | -42.85% | 0.22x | 1.83x | Nkr-75.85 Million |
Industry Comparison
This section compares Oncoinvent ASA's net assets metrics with peer companies in the Farm Products industry.
Industry Context
- Industry: Farm Products
- Average net assets among peers: $1,773,108,079
- Average return on equity (ROE) among peers: -43.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Oncoinvent ASA (KLDVK) | Nkr277.49 Million | 1.78% | 0.83x | $68.70 Million |
| African Agriculture Holdings Inc. (AAGR) | $-13.80 Million | 0.00% | 0.00x | $4.56 |
| Archer-Daniels-Midland Company (ADM) | $7.07 Billion | 6.38% | 1.43x | $33.40 Billion |
| Forafric Global PLC Ordinary Shares (AFRI) | $5.32 Million | -457.58% | 45.29x | $298.49 Million |
| Adecoagro SA (AGRO) | $1.79 Billion | -0.47% | 1.93x | $1.36 Billion |
| Agroz Inc. Ordinary Shares (AGRZ) | $5.37 Million | 69.97% | 3.21x | $9.56 Million |
| Alico Inc (ALCO) | $77.40 Million | 5.68% | 0.48x | $284.60 Million |
| AquaBounty Technologies Inc (AQB) | $9.33 Million | -71.38% | 0.38x | $4.84 Million |
| Bunge Limited (BG) | $6.08 Billion | 8.57% | 1.36x | $19.97 Billion |
| Cal-Maine Foods Inc (CALM) | $1.01 Billion | 0.20% | 0.23x | $2.92 Billion |
| Del Monte Corporation (DMC) | $1.70 Billion | 8.49% | 0.53x | $1.39 Billion |
About Oncoinvent ASA
Kaldvik AS engages in the salmon farming business in Iceland. It also operates smolt stations. The company was incorporated in 2020 and is headquartered in Eskifjörður, Iceland. Kaldvik AS was formerly known as Ice Fish Farm AS and changed its name to Kaldvik AS in August 2024. Kaldvik AS operates as a subsidiary of Austur Holding As.